GlassScriptPhysician profile
Eddy Mizrahi
NPI 1174840821
$27,238.39
in general payments reported to CMS, 2019-2025
42 companies · $7,064 in 2025
The $7,064 reported for 2025 was more than what 93% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,418 · 2020: $1,489 · 2021: $3,574 · 2022: $2,844 · 2023: $2,724 · 2024: $7,125 · 2025: $7,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,414 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $7,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,413.51 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $7,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $9,566.12 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $4,078.15 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $2,070.80 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Pfizer INC. | $1,524.38 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,228.96 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $992.06 | 2021-2025 | Verquvo, Capvaxive |
| E.R. Squibb & Sons, L.L.C. | $954.72 | 2019-2025 | Camzyos, Eliquis |
| Amgen INC. | $775.52 | 2019-2024 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $772.74 | 2019-2025 | Jardiance |
| Abbott Laboratories | $763.90 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip, Cardiomems |
| Boston Scientific Corporation | $597.11 | 2019-2024 | Watchman Access System |
| Bridgebio Pharma, INC. | $374.19 | 2025 | Attruby |
| Alnylam Pharmaceuticals INC. | $356.20 | 2020-2025 | Onpattro, Amvuttra |
| Novo Nordisk INC | $352.45 | 2024-2025 | Ozempic, Wegovy |
| Aop Health US, LLC | $333.31 | 2025 | Rapiblyk |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $307.60 | 2021-2024 | Cobalt Dr Mri Surescan, Micra, Onyx Frontier |
| Edwards Lifesciences Corporation | $242.71 | 2019-2025 | Pascal |
| Akcea Therapeutics, INC. | $210.35 | 2019-2021 | |
| Impulse Dynamics (USA) INC. | $206.94 | 2023-2024 | Optimizer, Optimizer |
| Kiniksa Pharmaceuticals, LTD. | $195.14 | 2023 | Arcalyst |
| Lantheus Medical Imaging, INC. | $184.81 | 2019-2024 | |
| Abiomed | $152.63 | 2022-2025 | Impella |
| Actelion Pharmaceuticals US, INC. | $150.58 | 2025 | Opsumit, Uptravi |
| Biotronik INC. | $105.58 | 2023-2025 | Renamic Neo |
| Teva Pharmaceuticals USA, INC. | $102.63 | 2024 | Uzedy |
| Atricure, INC. | $74.19 | 2022-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Amarin Pharma, INC. | $69.67 | 2019-2020 | |
| Lilly USA, LLC | $67.33 | 2025 | Zepbound, Mounjaro |
| Kestra Medical Technology Services, INC. | $62.94 | 2025 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $46.04 | 2022-2023 | |
| La Jolla Pharmaceutical Company | $36.19 | 2024-2025 | Giapreza |
| Esperion Therapeutics, INC. | $35.46 | 2021 | |
| Corcym INC | $34.56 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $32.99 | 2019 | |
| Ethicon US, LLC | $31.55 | 2025 | Surgicel Nu-Knit |
| Lexicon Pharmaceuticals, INC. | $31.16 | 2024 | |
| Davol INC. | $26.37 | 2020 | |
| United Therapeutics Corporation | $21.78 | 2024 | Tyvaso |
| Inspire Medical Systems, INC. | $19.95 | 2025 | Inspire |
| Kiniksa Pharmaceuticals International, Plc | $18.52 | 2024 | Arcalyst |
| Watermark Medical, INC. | $18.02 | 2025 | |
| Terumo Medical Corporation | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eddy Mizrahi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.